Sec Form 4 Filing - CAPEK JOHN M @ ABBOTT LABORATORIES - 2012-03-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person CAPEK JOHN M 2. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Executive Vice President (Last) (First) (Middle) 100 ABBOTT PARK ROAD 3. Date of Earliest Transaction (MM/DD/YY) 03/05/2012 (Street) ABBOTT PARK, IL60064-6400 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common shares without par value 03/05/2012 M 100,000 A $ 41.92 315,551 D Common shares without par value 03/05/2012 S 3,000 D $ 57.31 312,551 D Common shares without par value 03/05/2012 S 400 D $ 57.315 312,151 D Common shares without par value 03/05/2012 S 6,055 D $ 57.32 306,096 D Common shares without par value 03/05/2012 S 200 D $ 57.325 305,896 D Common shares without par value 03/05/2012 S 6,900 D $ 57.33 298,996 D Common shares without par value 03/05/2012 S 1,300 D $ 57.335 297,696 D Common shares without par value 03/05/2012 S 4,200 D $ 57.34 293,496 D Common shares without par value 03/05/2012 S 500 D $ 57.345 292,996 D Common shares without par value 03/05/2012 S 6,800 D $ 57.35 286,196 D Common shares without par value 03/05/2012 S 1,600 D $ 57.355 284,596 D Common shares without par value 03/05/2012 S 100 D $ 57.359 284,496 D Common shares without par value 03/05/2012 S 8,800 D $ 57.36 275,696 D Common shares without par value 03/05/2012 S 1,000 D $ 57.365 274,696 D Common shares without par value 03/05/2012 S 100 D $ 57.3675 274,596 D Common shares without par value 03/05/2012 S 100 D $ 57.369 274,496 D Common shares without par value 03/05/2012 S 12,700 D $ 57.37 261,796 D Common shares without par value 03/05/2012 S 2,700 D $ 57.375 259,096 D Common shares without par value 03/05/2012 S 10,327 D $ 57.38 248,769 D Common shares without par value 03/05/2012 S 1,773 D $ 57.385 246,996 D Common shares without par value 03/05/2012 S 200 D $ 57.3875 246,796 D Common shares without par value 03/05/2012 S 16,005 D $ 57.39 230,791 D Common shares without par value 03/05/2012 S 2,400 D $ 57.395 228,391 D Common shares without par value 03/05/2012 S 12,840 D $ 57.4 215,551 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Option (right to buy) ( 1 ) $ 41.92 03/05/2012 M 100,000 04/21/2009 04/20/2016 Common shares 100,000 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other CAPEK JOHN M 100 ABBOTT PARK ROAD ABBOTT PARK, IL60064-6400 Executive Vice President Signatures John A. Berry, by power of attorney for John M. Capek 03/07/2012 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.